Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Therapeutic Category
Antibacterials, Antibiotic, Anti-Inflammatories, Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹89/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tobraxyle D Eye Drop combines Dexamethasone (0.1%) and Tobramycin (0.3%), offering a dual-action formulation for treating eye conditions that involve inflammation and bacterial infection. Dexamethasone, a corticosteroid, works by reducing inflammation and swelling in the eye, while Tobramycin, an aminoglycoside antibiotic, targets and eliminates the bacteria causing the infection. This combination makes Tobraxyle D Eye Drop an effective treatment for bacterial conjunctivitis, post-surgical inflammation, or other eye infections where inflammation and bacterial infection coexist.
The eye drop formulation is designed to provide direct action at the site of infection, helping to alleviate symptoms such as redness, swelling, itching, and discharge. It can also prevent complications caused by bacterial infections and inflammation in the eye, promoting faster recovery and reducing the risk of more severe conditions such as corneal ulcers.
Possible side effects include eye irritation, burning or stinging upon application, and potential increased intraocular pressure with prolonged use.
For the treatment of bacterial eye infections with accompanying inflammation, such as conjunctivitis and post-surgical eye inflammation.
For external use only. Do not touch the tip of the dropper to any surface to avoid contamination. Use as directed by a healthcare provider.
Store the eye drop in a cool, dry place, away from direct sunlight. Do not freeze. Keep the bottle tightly closed when not in use.
Composition : Tobramycin (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Ofloxacin (0.3% w/v) Eye Ear Drops
Composition : Ofloxacin (0.3% w/v) + Ketorolac (0.5% w/v)
Composition : Amoxycillin (80mg) + Clavulanic Acid (11.4mg) Drops
Composition : Dicyclomine (10mg) + Dimethicone (40mg)
Composition : Hydroxyzine (6mg) Drops
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This antibiotic–steroid ophthalmic combination has strong demand in the eye care segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in eye infections, post-operative inflammation, bacterial conjunctivitis with inflammation, and other ophthalmic conditions managed by eye specialists. It is widely used in clinical ophthalmology practice.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dexamethasone 0.1% w/v + Tobramycin 0.3% w/v Eye Drops with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady ophthalmology prescriptions, repeat clinic demand, and strong hospital and eye-care segment sales when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.